Danish Pharmacovigilance Update, 29 August 2013

In this issue of Danish Pharmacovigilance Update:

News from the EU

• Cases of acquired haemophilia following treatment with clopidogrel (Plavix® etc.)
• Change in indication and contraindication for panitumumab (Vectibix®)
• Review of medicines containing zolpidem
• European Medicines Agency recommends suspension of medicines containing ketoconazole for oral use
• New recommendations for the use of painkillers containing diclofenac
• Until further notice, plasma substitutes containing hydroxyethyl starch (HES) for volume replacement in case of blood or plasma loss should be avoided in critically ill patients – including patients with sepsis
• Restrictions on the use of codeine for pain relief in children
• Risk of developing peripheral neuropathy during use of the fluoroquinolones class of antibiotics

 News from the Danish Health and Medicines Authority

• Report of urinary retention in association with the use of atomoxetine
• The Danish Health and Medicines Authority's report on NSAIDs – a study of the number of users, reported suspected adverse reactions and inadvertent incidents

 Short news

• Strong interest in Drug Analysis Prints with data from Danish adverse reaction reports
• The Danish Health and Medicines Authority: Information about cervical cancer and HPV vaccination